Climate Change Data

Environmental Metrics

ESG Focus Areas

• Compliance and Corporate Governance
• Social Responsibility
• Access to Medicines
• Philanthropy (HIV/AIDS in Africa)

Environmental Achievements

• Opened environmentally sensitive Pediatric Centers of Excellence in Lesotho, Swaziland, and Botswana (with plans for Uganda, Burkina Faso, and China)

Social Achievements

• Launched new policy on direct-to-consumer advertising, foregoing all DTC advertising of new products for at least one year after launch
• Launched new policy on disclosure of information from clinical trials, disclosing results regardless of development phase or outcome
• Provided more than $600 million in free medicines to over 800,000 people through company access program
• Participated in PhRMA’s Partnership for Prescription Assistance, helping over 1.6 million people
• Funded the first-ever Pediatric AIDS Corps of physicians for Africa
• Opened pediatric HIV/AIDS medical centers in Lesotho and Swaziland

Governance Achievements

• Separated the positions of Chairman and Chief Executive Officer
• Resolved investigation by U.S. Attorney's Office in New Jersey relating to wholesaler inventory and accounting matters through a Deferred Prosecution Agreement (DPA)

Climate Goals & Targets

Environmental Challenges

• Generic competition for several key products (Pravachol, TAXOL, Paraplatin, Glucophage)
• Loss of market exclusivity for several products
• Pricing pressures and controls in the U.S. and internationally
• Significant pending lawsuits and investigations
• Operating cost pressures

Mitigation Strategies

• Increased investments in R&D (10% growth over 2004)
• Focus on growth drivers and specialty products
• Realignment of sales force to focus on specialists and high-value primary care physicians
• Company-wide effort to realize $600 million in additional savings in 2007-2008
• Strengthening compliance infrastructure and instilling a culture of integrity

Supply Chain Management

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• Goal 3: Good Health and Well-being
• Goal 10: Reduced Inequalities

Initiatives related to access to medicines and philanthropic efforts in Africa contribute to these goals.

Awards & Recognition

• Ranked among the world’s 100 Most Sustainable Corporations
• ConvaTec received Technology Innovation and Leadership of the Year award
• Bristol-Myers Squibb wins Team of the Year Award
• Working Mother magazine names Bristol-Myers Squibb one of the 10 Best Companies for Working Mothers

Environmental Metrics

ESG Focus Areas

• Access to Healthcare
• Environmental Footprint
• Renewable Energy, Green Processes
• Green Design, Green Laboratories
• Safety and Health
• Employee Engagement
• Community Investment
• Supplier Sustainability

Environmental Achievements

• Reduced packaging waste by 5%
• Reduced total energy use and greenhouse gas emissions by 15%
• Reduced total water use by 10%
• Reduced Abilify packaging insert size, saving 70 tons of paper, 1.5 million gallons of water, and $1.8 million
• Consolidated 29 US distribution centers into one, saving an estimated $1.9 million in transportation costs and 680,000 tons of carbon emissions
• Reduced land/f_ill waste in Australia by 100 tons per year through reusable cold chain packaging
• Installed solar energy system at Hopewell R&D facility, reducing greenhouse gas emissions by 476 tons per year

Social Achievements

• Launched new philanthropic initiative to address inequities in access to specialty healthcare services in the US
• Expanded Bridging Cancer Care initiative to address lung cancer in the southeastern US
• Expanded SECURE THE FUTURE initiative to address cervical and breast cancers among women living with HIV in sub-Saharan Africa
• Supported ENGAGE-TB initiative to strengthen community-based care for patients with TB, including those with HIV
• Supported Delivering Hope initiative to address hepatitis B and C in Asia
• Supported Mental Health & Well-Being initiative focusing on community-based solutions for veterans, military service members, and their families
• Supported Together on Diabetes initiative to improve diabetes care and outcomes in the US, China, and India
• Implemented a Safety Culture Champions program (SPYDRs) to enhance safety awareness
• Launched Vets Prevail, an online behavioral health solution for veterans
• Implemented the Theater of War program to help soldiers and their families deal with the effects of war
• Implemented Staying Strong, a web-based initiative to support military families and school professionals working with military-connected children
• Implemented Compañeros en Salud program linking type 2 diabetes patients with promotores (community health workers)

Governance Achievements

• Achieved No. 1 overall ranking on Corporate Responsibility magazine’s annual list of the 100 Best Corporate Citizens

Climate Goals & Targets

Environmental Challenges

• Inequities in access to specialty healthcare services in the US
• High lung cancer mortality rates in the southeastern US
• High rates of cervical and breast cancer among women with HIV in Africa
• High rates of TB among people with HIV in sub-Saharan Africa
• High rates of hepatitis B and C in Asia
• Mental health needs of veterans and military families
• High rates of type 2 diabetes in the US, China, and India
• Work-related injuries and illnesses

Mitigation Strategies

• New grants program to address barriers to specialty care
• Expansion of Bridging Cancer Care and SECURE THE FUTURE initiatives
• Collaboration with WHO on ENGAGE-TB
• Delivering Hope initiative to address hepatitis B and C
• Vets Prevail online behavioral health solution
• Theater of War program
• Staying Strong program for military families
• Compañeros en Salud program for diabetes patients
• Comprehensive occupational safety and health program
• DuPont STOP (Safety Training Observation Program)

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Expand principles of sustainability and performance indicators at key suppliers

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: LEED Silver (ZymoGenetics)

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Ranked No.1 Overall by Corporate Responsibility Magazine (2014)
• Top 50 Most Advanced US Companies for Environmental, Social and Governance Performance (2013)
• Best Company for Working Mothers (2013)
• Compliance Leader Verification Award (2014)

Environmental Metrics

ESG Focus Areas

• Patients
• Employees
• Global Communities
• Shareholders
• Environment

Environmental Achievements

• 462 labs at 11 company facilities certified under Green Labs program (up from 60 labs in 2014)
• New and renovated facilities in Devens, MA, and Seattle, WA, received LEED® Silver certification
• 750 kW solar photovoltaic project installed at Hopewell, NJ site
• Logistics initiatives changed product shipment from air to ocean, reducing CO2 emissions by 95% and lowering annual transportation costs by $7,000,000
• Humacao, Puerto Rico facility energy treasure hunt identified potential 21% reduction in energy use and 2% reduction in water consumption

Social Achievements

• Bristol-Myers Squibb Foundation programs reached 207,357 women through cervical cancer education and mobilization
• 12,491 breast exams conducted and 2,820 professional medical workers trained
• Finance GIVEs program helped more than 30 nonprofit partners improve financial and management systems
• Patient Assistance Foundation assisted nearly 86,000 patients with $694 million in support
• Over 7,000 employees in 44 countries participated in People and Business Resource Groups (PBRGs)

Governance Achievements

• Comprehensive integrity training program completed by nearly 100% of workforce
• Compliance and Ethics Helpline maintained for employee inquiries and anonymous reporting
• Active Supplier Diversity program to drive business results and build economic strength of local communities

Climate Goals & Targets

Environmental Challenges

• Inequities in access to specialty care services for vulnerable populations
• High rates of lung cancer in the southeastern U.S.
• High rates of cervical cancer among women in sub-Saharan Africa
• High rates of HIV infection and cervical cancer among sex workers in South Africa
• Lack of diagnosis and trained healthcare workforce for pediatric cancer in sub-Saharan Africa

Mitigation Strategies

• Bristol-Myers Squibb Foundation's Bridging Cancer Care initiative to expand community-based resources and survivorship support programs
• SECURE THE FUTURE program expanded to address cervical cancer in sub-Saharan Africa using mobile technology
• Finance GIVEs program providing skills-based volunteering to improve financial and management systems of nonprofit partners
• Patient Assistance Foundation providing financial assistance for medication
• Bristol-Myers Squibb Foundation's commitment to create a transformational pediatric oncology treatment and training program in Africa

Supply Chain Management

Responsible Procurement

• Supplier Diversity program

Climate-Related Risks & Opportunities

Awards & Recognition

• FORTUNE magazine's World's Most Admired Companies
• ENERGY STAR Partner of the Year
• Corporate Responsibility magazine's 100 Best Corporate Citizens
• Working Mother 100 Best Companies
• Corporate Equality Index (CEI)
• NAFE Top Companies for Executive Women
• Dow Jones Sustainability Index

Environmental Metrics

ESG Focus Areas

• Patient access to medicines
• Employee well-being and diversity
• Supply chain sustainability
• Environmental footprint reduction
• Ethical business conduct

Environmental Achievements

• Reduced greenhouse gas emissions by more than 24%
• Reduced water use by about 14%
• Purchased 29 million kilowatt hours of green energy in Germany and Ireland
• 64% reduction in organic food waste at Sao Paulo site through on-site composting and sustainable garden

Social Achievements

• Launched Global HOPE initiative to improve pediatric cancer care in Africa
• Expanded access to specialty care for vulnerable populations in the U.S.
• Supported Make-A-Wish Foundation to fulfill wishes for children with cancer
• Launched mobile lung screening unit in North and South Carolina
• Implemented U.S. Family Leave Program with extended paid time off
• Supported various community initiatives globally through employee volunteering and giving programs

Governance Achievements

• Comprehensive integrity training program completed by nearly 100% of workforce
• Maintained Compliance and Ethics Integrity Line for reporting concerns
• Commitment to transparency in clinical trials, grants, and interactions with healthcare professionals

Climate Goals & Targets

Environmental Challenges

• Inequities in access to specialty care
• High lung cancer incidence and mortality rates in certain regions
• Limited access to pediatric cancer treatment in some parts of the world
• Hurricane Maria's impact on Puerto Rico operations
• Water resource limitations

Mitigation Strategies

• Global HOPE initiative
• Grants to safety net providers for specialty care
• Mobile lung screening unit
• Partnership with The Max Foundation for medication access
• Relief supplies and operational support in Puerto Rico
• Wastewater initiative to improve water use and treatment

Supply Chain Management

Responsible Procurement

• Engagement with suppliers on quality, labor, integrity, and environmental standards

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals

Certifications: LEED Gold Certification (Lawrence Township, NJ office)

Awards & Recognition

• Fortune's World's Most Admired Companies
• 100 Best Corporate Citizens
• Working Mother 100 Best Companies
• CareerBliss Happiest Companies in America
• Best-of-the-Best Corporations for Inclusion
• NAFE Top Companies for Executive Women
• Military Friendly Company
• Dow Jones' 2018 North American Index of Leading Sustainable Companies
• Forbes and JUST Capital's 100 Most JUST Companies
• 100% Score on the 2018 Corporate Equality Index
• 2018 Energy Star Partner of the Year - Sustained Excellence Award

Environmental Metrics

ESG Focus Areas

• Environmental Stewardship
• Global Diversity & Inclusion
• Responsibility

Environmental Achievements

• 18% reduction in absolute GHG emissions (against 5% goal)
• 20% of BMS energy is cogenerated
• 50% decrease in transportation-related GHG emissions for Orencia® and Opdivo®
• 6% reduction in water usage from 2015 baseline (against 5% goal)
• 100% of our manufacturing sites evaluated for waste-water practices (3-year study completed across 13 sites in 6 countries)
• Launched our first zero-waste-to-landfill and 100% green energy manufacturing facility in Cruiserath, Ireland

Social Achievements

• Strong external recognition of the excellence of our environmental, social and governance programs
• People and Business Resource Groups (PBRGs) with over 11,000 global members driving business performance, innovation and leadership development.
• Initiatives to improve health, expand research opportunities, promote STEM education, and deliver basic human services to communities.
• Promoting health equity globally and striving to increase access to life-saving medicines.

Governance Achievements

• Added a key integration metric to our executive compensation plans to measure success in Celgene integration.

Climate Goals & Targets

Environmental Challenges

• Increased burden that healthcare costs may place on patients, families and caregivers.
• Affordability of life-saving medicines.

Mitigation Strategies

• Actively engaged in the global dialogue to address the affordability of life-saving medicines.
• Working to advance policies that support and reward investments in the discovery and development of life-saving medicines.
• Providing greater access to our medicines in global markets through tiered pricing, voluntary licensing, reimbursement support, patient assistance programs and our Bristol Myers Squibb Foundation partnerships.

Supply Chain Management

Responsible Procurement

• Incorporating the principles of green chemistry and green engineering to reduce environmental impact across the supply chain.

Climate-Related Risks & Opportunities

Environmental Metrics

ESG Focus Areas

• Ethical Business
• Innovation, Health Equity and Patient Access
• Our People
• Environmental Responsibility

Environmental Achievements

• Met or exceeded all 19 targets in support of our five Sustainability 2020 Goals
• Avoided the generation of >1,000MT chemical process across nine projects (2016-2020) through Green Chemistry efforts
• Named as U.S. Environmental Protection Agency ENERGY STAR Partner of the Year: Sustained Excellence for the seventh consecutive year as of April 21, 2021

Social Achievements

• Issued Global Diversity & Inclusion Report
• Spent more than $695 million globally with diverse business enterprises, striving toward our goal of $1 billion by 2025
• Established new Health Equity and Diversity & Inclusion commitments

Governance Achievements

• Published inaugural report on our anti-corruption compliance program based on guidance from Norges Bank Investment Management and the Basel Institute on Governance

Climate Goals & Targets

Environmental Challenges

• COVID-19 pandemic impacting operations and clinical trials
• Need for greater diversity in clinical research
• Systemic barriers to access to medicines in LMICs

Mitigation Strategies

• Established guidelines and principles for clinical trials during COVID-19
• Launched Diversity in Clinical Trials initiative
• Implemented various capacity-building initiatives and demonstration projects in LMICs

Supply Chain Management

Responsible Procurement

• Supplier Diversity program
• BMS Standards of Business Conduct and Ethics for Third Parties

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Biopharma Investor ESG Communications Guidance 2.0, SASB, TCFD, GRI, NBIM

Awards & Recognition

• U.S. Environmental Protection Agency ENERGY STAR Partner of the Year: Sustained Excellence

Environmental Metrics

ESG Focus Areas

• Ethical Business
• Innovation, Health Equity and Patient Access
• Our People
• Environmental Responsibility

Environmental Achievements

• 7% reduction in energy use since 2019
• 10.9% reduction in overall waste generated
• Reduced CO2 emissions by 33% with the implementation of new shipping containers in two key shipping lanes
• 100% reduction in Sulphur Oxide, 91% reduction in Nitrogen Oxide, and 29% reduction in Carbon Dioxide through the conversion of barges to ocean vessels powered by Liquified Natural Gas (LNG) between the U.S. & Puerto Rico
• Reduced CO2 emissions by ~70% converting from air to ocean mode for vendor shipments to Puerto Rico
• 3 Ton carbon emissions reduction in Argentina due to alignment of product order size and shipping container capacity

Social Achievements

• 54% of U.S. clinical trial sites were located in highly diverse communities, exceeding our goal
• Expanded Tomorrow’s Innovators program to recruit talent from Historically Black Colleges and Universities
• Increased diverse patient participation in clinical trials
• >619,000 people reached through Health Equity grants
• $899 million diverse supplier spend in 2021 (29% increase from 2020)
• 45.5% global executives are women (2.9% YOY increase)

Governance Achievements

• Improved Conflicts of Interest (COI) system
• Centralized and automated COI systems
• Robust anti-bribery policies and training for all employees and relevant contractors
• Completed more than 100 regulatory inspections in 2021
• Zero product safety incidents in 2021

Climate Goals & Targets

Environmental Challenges

• Supply chain disruptions due to the COVID-19 pandemic
• Counterfeit medicines
• Cybersecurity threats
• Managing Scope 3 emissions

Mitigation Strategies

• Implemented security technologies to protect products from counterfeiting
• Collaborated with industry coalitions and law enforcement on product security
• Implemented cybersecurity and data privacy programs aligned with NIST CSF
• Engaged in real-time education of the global workforce on cybersecurity
• Expanded tracking and management of Scope 3 emissions

Supply Chain Management

Supplier Audits: 100% of high-risk third parties audited

Responsible Procurement

• Sustainability embedded as a value driver in supplier partnership and innovation
• Responsible Sourcing program

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Biopharma Investor ESG Communications Guidance 2.0, GRI Standards, SASB Standards for the biopharmaceutical sector, Norges Bank Investment Management (NBIM) guidance

Certifications: ENERGY STAR

Third-party Assurance: Limited assurance

UN Sustainable Development Goals

• Goal 3: Good Health and Well-being
• Goal 4: Quality Education
• Goal 10: Reduced Inequalities
• Goal 13: Climate Action

Mapped sustainability efforts to 11 of the UN SDGs

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• 2021 EPA Green Chemistry Challenge Award
• Forbes Green Growth 50 list

Environmental Metrics

ESG Focus Areas

• Environmental Sustainability
• Social Responsibility
• Governance
• Health Equity
• Inclusion and Diversity

Social Achievements

• Promoting health equity and improving health outcomes for populations disproportionately affected by serious diseases
• Fostering an environment of inclusion and belonging and building a globally diverse workforce

Governance Achievements

• Strong governance profile with direct oversight by the Board of Directors, including the Committee on Directors and Corporate Governance (CDCG) and the Compensation and Management Development Committee (CMDC)

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SASB

Environmental Metrics

ESG Focus Areas

• Advancing patient health around the world
• Fostering a high-performing and inclusive global workforce
• Expanding the boundaries of science
• Sustaining our planet and improving health

Environmental Achievements

• Published inaugural Task Force on Climate-related Financial Disclosures (TCFD) Report
• Announced a second 15-year Virtual Power Purchasing Agreement (VPPA) with National Grid Renewables for 145 megawatts of solar energy
• Implemented more than 70 projects to reduce energy use and greenhouse gas (GHG) emissions

Social Achievements

• Reached 12M+ patients globally through emerging market brands
• Reached >80 LMICs with 12 transformative products
• 58% of clinical trial sites were located in racially and ethnically diverse metro areas of the U.S.
• Published our inaugural Task Force on Climate-related Financial Disclosures (TCFD) Report and submitted our science-based targets to the Science Based Targets initiative (SBTi) for external validation.
• Increased number of gender-diverse investigators globally to 23% female investigators
• Implemented voluntary self-identification for patients of sexual orientation, gender identity, and intersex status (SOGIIS) in 11 clinical trials
• Provided $19.4M through 277 grants and donations to organizations supporting patients through projects and programs that address health equity.

Governance Achievements

• Established ESG Council in 2022
• Published ESG Governance Operating Model in 2022
• Included 10% of company performance factor in 2023 annual bonus plan for VPs and above based on an ESG scorecard metric.
• Received a score of 94.3 on the CPA-Zicklin Index of Corporate Political Disclosure and Accountability.

Climate Goals & Targets

Environmental Challenges

• Challenges to accessing medicines and adequate healthcare services globally
• Health inequities globally
• Barriers to achieving health equity
• Climate change impacts on global public health
• Drug shortages
• Counterfeiting of medicines
• Cybersecurity threats
• Water scarcity

Mitigation Strategies

• Allocating specific resources and developing new pathways and models to expand access to patients in low- and middle-income countries (LMICs)
• Embedding access considerations as a core tenet across our business
• Developing tailored programs to help improve access to our innovative portfolio in LMICs
• Forging global policy partnerships to help strengthen healthcare systems
• Strengthening the resiliency of our supply chain
• Proactive collaboration with health authorities
• Implementing a forward-looking supply risk assessment process
• Implementing multiple and diverse efforts to ensure the integrity of our products within the global supply chain
• Partnering with vendors who monitor the dark web for potential counterfeited or diverted drugs
• Participating in industry coalitions and organizations addressing counterfeiting
• Constantly evolving cyber defenses
• Implementing a multi-pronged approach to safeguard assets and data
• Implementing several projects and retrofits to save both water and energy
• Enacting use-modeling and utilizing water balance maps to identify opportunities to reuse, repurpose and recycle water at our facilities

Supply Chain Management

Supplier Audits: ~700/year

Responsible Procurement

• Code of conduct
• Supplier sustainability requirements
• Manufacture 2030
• Energize
• Converge

Climate-Related Risks & Opportunities

Transition Risks

• Legislative or regulatory actions impacting the pharmaceutical industry

Reporting Standards

Frameworks Used: SASB, UN SDGs, UN Global Compact, CDP, TCFD, GRI

Third-party Assurance: Apex Companies, LLC (limited assurance)

Awards & Recognition

• Energy Star Top Project of the Year
• CPHI Sustainability Award
• 2023 Menopause-Friendly Employer Awards

Environmental Metrics

ESG Focus Areas

• Climate Change

Environmental Achievements

• Reduced Scope 1 and 2 GHG emissions by -1.6% and -2.1% respectively in 2023 from 2022.
• Reduced Scope 3 GHG emissions from FERA by -1.0% in 2023 from 2022.
• Achieved a 7.6% reduction in facility GHG emissions at the Aichi plant through initiatives like electric boilers and heat pumps.
• Secured SBTi approval for near-term and net-zero targets.
• Signed two VPPAs to procure renewable electricity, aiming for 100% renewable electricity in US operations by 2030.
• Installed PV arrays at multiple locations, generating nearly 2 MW of energy.

Social Achievements

• Not disclosed

Governance Achievements

• Expanded existing and established new working groups dedicated to driving climate action and accountability.
• Integrated climate considerations within the enterprise risk management (ERM) framework.
• Advanced the Double Materiality Assessment (DMA) in accordance with CSRD’s ESRS guidelines.

Climate Goals & Targets

Environmental Challenges

• Physical risks from extreme weather events (storms, wildfires), drought, extreme heat, and flooding.
• Transition risks related to cross-border carbon taxing on supply chain emissions and increased cost/decreased availability of key agricultural products.
• Regulatory compliance with evolving climate-related legislation (EU CSRD, IFRS S1 & S2).

Mitigation Strategies

• Expanded physical risk assessment to 180+ assets, incorporating six hazards.
• Introduced quantitative assessments for transition risks.
• Launched the BMS Supplier Decarbonization Accelerator to engage suppliers in setting science-based targets.
• Implementing a strategy that integrates sustainability into core operations and supplier relationships.
• Undertaking Life Cycle Assessment (LCA) efforts to identify and address environmental hotspots.
• Proactively aligning with new regulations such as the EU’s Corporate Sustainability Reporting Directive (CSRD) and International Financial Reporting Standards (IFRS) S1 and S2.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• BMS Responsible Sourcing Program (RSP)

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events
• Drought
• Extreme heat
• Flooding

Transition Risks

• Cross-border carbon taxing
• Increased cost and decreased availability of key agricultural products

Opportunities

• Renewable energy
• Energy efficiency

Reporting Standards

Frameworks Used: IFRS S1, IFRS S2, TCFD

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed